The story of Viagra, and its developer copyright, presents a challenging case study for investors. Initially a blockbuster drug, generating billions in revenue , its intellectual property lapse created a wave of generic competition , significantly eroding its market share . While certain pharmaceutical companies may seek to capitalize on male sexua